nodes	percent_of_prediction	percent_of_DWPC	metapath
Thioridazine—CYP2C8—Medroxyprogesterone Acetate—uterine cancer	0.139	0.186	CbGbCtD
Thioridazine—CYP2C9—Medroxyprogesterone Acetate—uterine cancer	0.0973	0.13	CbGbCtD
Thioridazine—CYP2C8—Progesterone—uterine cancer	0.0924	0.123	CbGbCtD
Thioridazine—CYP2C19—Progesterone—uterine cancer	0.0775	0.104	CbGbCtD
Thioridazine—CYP1A2—Progesterone—uterine cancer	0.0715	0.0956	CbGbCtD
Thioridazine—CYP2C9—Progesterone—uterine cancer	0.0644	0.0861	CbGbCtD
Thioridazine—CYP2D6—Progesterone—uterine cancer	0.0589	0.0788	CbGbCtD
Thioridazine—CYP2E1—Etoposide—uterine cancer	0.0553	0.074	CbGbCtD
Thioridazine—CYP2C8—Etoposide—uterine cancer	0.0413	0.0553	CbGbCtD
Thioridazine—CYP1A2—Etoposide—uterine cancer	0.032	0.0428	CbGbCtD
Thioridazine—CYP2D6—Doxorubicin—uterine cancer	0.018	0.024	CbGbCtD
Thioridazine—Hyperpyrexia—Medroxyprogesterone Acetate—uterine cancer	0.00694	0.0364	CcSEcCtD
Thioridazine—Parkinsonism—Medroxyprogesterone Acetate—uterine cancer	0.00569	0.0298	CcSEcCtD
Thioridazine—Menstruation irregular—Progesterone—uterine cancer	0.00515	0.027	CcSEcCtD
Thioridazine—Menstruation irregular—Medroxyprogesterone Acetate—uterine cancer	0.00467	0.0245	CcSEcCtD
Thioridazine—Galactorrhoea—Progesterone—uterine cancer	0.0044	0.023	CcSEcCtD
Thioridazine—Laryngeal oedema—Medroxyprogesterone Acetate—uterine cancer	0.00403	0.0211	CcSEcCtD
Thioridazine—Galactorrhoea—Medroxyprogesterone Acetate—uterine cancer	0.00398	0.0209	CcSEcCtD
Thioridazine—Cholestasis—Progesterone—uterine cancer	0.00376	0.0197	CcSEcCtD
Thioridazine—Eruption—Dactinomycin—uterine cancer	0.00328	0.0172	CcSEcCtD
Thioridazine—Amenorrhoea—Progesterone—uterine cancer	0.00325	0.017	CcSEcCtD
Thioridazine—Blood disorder—Medroxyprogesterone Acetate—uterine cancer	0.00309	0.0162	CcSEcCtD
Thioridazine—Amenorrhoea—Medroxyprogesterone Acetate—uterine cancer	0.00294	0.0154	CcSEcCtD
Thioridazine—HTR7—artery—uterine cancer	0.00292	0.0609	CbGeAlD
Thioridazine—Hepatotoxicity—Dactinomycin—uterine cancer	0.00261	0.0137	CcSEcCtD
Thioridazine—Nasal congestion—Progesterone—uterine cancer	0.00227	0.0119	CcSEcCtD
Thioridazine—Aplastic anaemia—Dactinomycin—uterine cancer	0.00189	0.00992	CcSEcCtD
Thioridazine—Hepatotoxicity—Etoposide—uterine cancer	0.00189	0.0099	CcSEcCtD
Thioridazine—Psychotic disorder—Medroxyprogesterone Acetate—uterine cancer	0.00183	0.0096	CcSEcCtD
Thioridazine—HTR2A—artery—uterine cancer	0.00182	0.038	CbGeAlD
Thioridazine—Asthma—Progesterone—uterine cancer	0.00179	0.00938	CcSEcCtD
Thioridazine—ADRA1B—renal system—uterine cancer	0.00176	0.0368	CbGeAlD
Thioridazine—Sweating increased—Progesterone—uterine cancer	0.00174	0.00913	CcSEcCtD
Thioridazine—Weight increased—Progesterone—uterine cancer	0.00163	0.00853	CcSEcCtD
Thioridazine—Asthma—Medroxyprogesterone Acetate—uterine cancer	0.00162	0.0085	CcSEcCtD
Thioridazine—Drowsiness—Progesterone—uterine cancer	0.0016	0.00836	CcSEcCtD
Thioridazine—Sweating increased—Medroxyprogesterone Acetate—uterine cancer	0.00158	0.00828	CcSEcCtD
Thioridazine—Jaundice—Progesterone—uterine cancer	0.00155	0.00815	CcSEcCtD
Thioridazine—Body temperature increased—Carboplatin—uterine cancer	0.00153	0.00802	CcSEcCtD
Thioridazine—Lethargy—Dactinomycin—uterine cancer	0.00149	0.00783	CcSEcCtD
Thioridazine—Weight increased—Medroxyprogesterone Acetate—uterine cancer	0.00148	0.00773	CcSEcCtD
Thioridazine—Drowsiness—Medroxyprogesterone Acetate—uterine cancer	0.00145	0.00758	CcSEcCtD
Thioridazine—Oedema peripheral—Progesterone—uterine cancer	0.00141	0.00739	CcSEcCtD
Thioridazine—Jaundice—Medroxyprogesterone Acetate—uterine cancer	0.00141	0.00739	CcSEcCtD
Thioridazine—Eruption—Epirubicin—uterine cancer	0.00133	0.00697	CcSEcCtD
Thioridazine—KCNH2—myometrium—uterine cancer	0.00131	0.0274	CbGeAlD
Thioridazine—Oedema peripheral—Medroxyprogesterone Acetate—uterine cancer	0.00128	0.0067	CcSEcCtD
Thioridazine—Mental disorder—Progesterone—uterine cancer	0.00125	0.00658	CcSEcCtD
Thioridazine—Erythema—Progesterone—uterine cancer	0.00125	0.00653	CcSEcCtD
Thioridazine—Eruption—Doxorubicin—uterine cancer	0.00123	0.00645	CcSEcCtD
Thioridazine—Pancytopenia—Dactinomycin—uterine cancer	0.0012	0.00629	CcSEcCtD
Thioridazine—Vision blurred—Progesterone—uterine cancer	0.00117	0.00616	CcSEcCtD
Thioridazine—Tremor—Progesterone—uterine cancer	0.00117	0.00612	CcSEcCtD
Thioridazine—Anaemia—Progesterone—uterine cancer	0.00115	0.00604	CcSEcCtD
Thioridazine—Angioedema—Progesterone—uterine cancer	0.00114	0.00597	CcSEcCtD
Thioridazine—Mental disorder—Medroxyprogesterone Acetate—uterine cancer	0.00114	0.00596	CcSEcCtD
Thioridazine—Erythema—Medroxyprogesterone Acetate—uterine cancer	0.00113	0.00592	CcSEcCtD
Thioridazine—HTR7—epithelium—uterine cancer	0.00111	0.0231	CbGeAlD
Thioridazine—Ventricular arrhythmia—Epirubicin—uterine cancer	0.0011	0.00579	CcSEcCtD
Thioridazine—HTR1A—renal system—uterine cancer	0.00107	0.0224	CbGeAlD
Thioridazine—ADRA1A—epithelium—uterine cancer	0.00107	0.0223	CbGeAlD
Thioridazine—HTR7—smooth muscle tissue—uterine cancer	0.00107	0.0223	CbGeAlD
Thioridazine—Tremor—Medroxyprogesterone Acetate—uterine cancer	0.00106	0.00555	CcSEcCtD
Thioridazine—Agranulocytosis—Dactinomycin—uterine cancer	0.00105	0.00551	CcSEcCtD
Thioridazine—HRH1—myometrium—uterine cancer	0.00105	0.022	CbGeAlD
Thioridazine—Anaemia—Medroxyprogesterone Acetate—uterine cancer	0.00104	0.00547	CcSEcCtD
Thioridazine—Agitation—Medroxyprogesterone Acetate—uterine cancer	0.00104	0.00544	CcSEcCtD
Thioridazine—ADRA2A—myometrium—uterine cancer	0.00103	0.0216	CbGeAlD
Thioridazine—Angioedema—Medroxyprogesterone Acetate—uterine cancer	0.00103	0.00541	CcSEcCtD
Thioridazine—Confusional state—Progesterone—uterine cancer	0.00103	0.00538	CcSEcCtD
Thioridazine—HTR7—renal system—uterine cancer	0.00103	0.0214	CbGeAlD
Thioridazine—Ventricular arrhythmia—Doxorubicin—uterine cancer	0.00102	0.00536	CcSEcCtD
Thioridazine—KCNH2—uterine cervix—uterine cancer	0.00102	0.0213	CbGeAlD
Thioridazine—HTR2C—female reproductive system—uterine cancer	0.00102	0.0213	CbGeAlD
Thioridazine—Oedema—Progesterone—uterine cancer	0.00102	0.00533	CcSEcCtD
Thioridazine—Cardiac arrest—Etoposide—uterine cancer	0.00101	0.00528	CcSEcCtD
Thioridazine—Tachycardia—Progesterone—uterine cancer	0.000993	0.0052	CcSEcCtD
Thioridazine—ADRA1A—renal system—uterine cancer	0.00099	0.0207	CbGeAlD
Thioridazine—Hyperhidrosis—Progesterone—uterine cancer	0.000984	0.00516	CcSEcCtD
Thioridazine—Blood disorder—Epirubicin—uterine cancer	0.000979	0.00513	CcSEcCtD
Thioridazine—Anorexia—Progesterone—uterine cancer	0.00097	0.00508	CcSEcCtD
Thioridazine—KCNH2—renal system—uterine cancer	0.000956	0.02	CbGeAlD
Thioridazine—Hypotension—Progesterone—uterine cancer	0.000951	0.00498	CcSEcCtD
Thioridazine—Amenorrhoea—Epirubicin—uterine cancer	0.000931	0.00488	CcSEcCtD
Thioridazine—Confusional state—Medroxyprogesterone Acetate—uterine cancer	0.00093	0.00487	CcSEcCtD
Thioridazine—KCNH2—endometrium—uterine cancer	0.000924	0.0193	CbGeAlD
Thioridazine—Oedema—Medroxyprogesterone Acetate—uterine cancer	0.000922	0.00483	CcSEcCtD
Thioridazine—Blood disorder—Doxorubicin—uterine cancer	0.000906	0.00475	CcSEcCtD
Thioridazine—Somnolence—Progesterone—uterine cancer	0.000905	0.00474	CcSEcCtD
Thioridazine—Thrombocytopenia—Medroxyprogesterone Acetate—uterine cancer	0.000903	0.00473	CcSEcCtD
Thioridazine—Tachycardia—Medroxyprogesterone Acetate—uterine cancer	0.0009	0.00472	CcSEcCtD
Thioridazine—Sweating increased—Etoposide—uterine cancer	0.000892	0.00467	CcSEcCtD
Thioridazine—Hyperhidrosis—Medroxyprogesterone Acetate—uterine cancer	0.000891	0.00467	CcSEcCtD
Thioridazine—Decreased appetite—Progesterone—uterine cancer	0.000884	0.00464	CcSEcCtD
Thioridazine—Erythema—Dactinomycin—uterine cancer	0.000881	0.00462	CcSEcCtD
Thioridazine—Anorexia—Medroxyprogesterone Acetate—uterine cancer	0.000879	0.00461	CcSEcCtD
Thioridazine—CYP2C8—renal system—uterine cancer	0.000874	0.0183	CbGeAlD
Thioridazine—Constipation—Progesterone—uterine cancer	0.00087	0.00456	CcSEcCtD
Thioridazine—Pancytopenia—Etoposide—uterine cancer	0.000869	0.00456	CcSEcCtD
Thioridazine—Hypotension—Medroxyprogesterone Acetate—uterine cancer	0.000862	0.00452	CcSEcCtD
Thioridazine—Amenorrhoea—Doxorubicin—uterine cancer	0.000861	0.00451	CcSEcCtD
Thioridazine—KCNH2—uterus—uterine cancer	0.000851	0.0178	CbGeAlD
Thioridazine—CYP2C8—endometrium—uterine cancer	0.000845	0.0177	CbGeAlD
Thioridazine—Feeling abnormal—Progesterone—uterine cancer	0.000838	0.00439	CcSEcCtD
Thioridazine—HRH1—epithelium—uterine cancer	0.000826	0.0172	CbGeAlD
Thioridazine—HTR7—female reproductive system—uterine cancer	0.000822	0.0172	CbGeAlD
Thioridazine—Somnolence—Medroxyprogesterone Acetate—uterine cancer	0.00082	0.0043	CcSEcCtD
Thioridazine—HRH1—uterine cervix—uterine cancer	0.000819	0.0171	CbGeAlD
Thioridazine—CYP1A2—renal system—uterine cancer	0.000818	0.0171	CbGeAlD
Thioridazine—Ventricular tachycardia—Epirubicin—uterine cancer	0.000818	0.00429	CcSEcCtD
Thioridazine—Anaemia—Dactinomycin—uterine cancer	0.000814	0.00427	CcSEcCtD
Thioridazine—Dermatitis contact—Epirubicin—uterine cancer	0.000808	0.00424	CcSEcCtD
Thioridazine—Abnormal dreams—Epirubicin—uterine cancer	0.000808	0.00424	CcSEcCtD
Thioridazine—Body temperature increased—Progesterone—uterine cancer	0.000804	0.00422	CcSEcCtD
Thioridazine—ADRA2A—uterine cervix—uterine cancer	0.000804	0.0168	CbGeAlD
Thioridazine—Decreased appetite—Medroxyprogesterone Acetate—uterine cancer	0.000801	0.0042	CcSEcCtD
Thioridazine—HRH1—smooth muscle tissue—uterine cancer	0.000796	0.0166	CbGeAlD
Thioridazine—Jaundice—Etoposide—uterine cancer	0.000795	0.00417	CcSEcCtD
Thioridazine—Leukopenia—Dactinomycin—uterine cancer	0.000789	0.00413	CcSEcCtD
Thioridazine—Constipation—Medroxyprogesterone Acetate—uterine cancer	0.000788	0.00413	CcSEcCtD
Thioridazine—HRH1—decidua—uterine cancer	0.00078	0.0163	CbGeAlD
Thioridazine—Aplastic anaemia—Epirubicin—uterine cancer	0.000768	0.00402	CcSEcCtD
Thioridazine—ADRA2A—decidua—uterine cancer	0.000766	0.016	CbGeAlD
Thioridazine—KCNH2—female reproductive system—uterine cancer	0.000765	0.016	CbGeAlD
Thioridazine—Agranulocytosis—Etoposide—uterine cancer	0.000762	0.00399	CcSEcCtD
Thioridazine—Feeling abnormal—Medroxyprogesterone Acetate—uterine cancer	0.00076	0.00398	CcSEcCtD
Thioridazine—Ventricular tachycardia—Doxorubicin—uterine cancer	0.000757	0.00397	CcSEcCtD
Thioridazine—Hypersensitivity—Progesterone—uterine cancer	0.00075	0.00393	CcSEcCtD
Thioridazine—Dermatitis contact—Doxorubicin—uterine cancer	0.000748	0.00392	CcSEcCtD
Thioridazine—Abnormal dreams—Doxorubicin—uterine cancer	0.000748	0.00392	CcSEcCtD
Thioridazine—HRH1—endometrium—uterine cancer	0.000741	0.0155	CbGeAlD
Thioridazine—CYP2E1—renal system—uterine cancer	0.000736	0.0154	CbGeAlD
Thioridazine—Body temperature increased—Medroxyprogesterone Acetate—uterine cancer	0.000729	0.00382	CcSEcCtD
Thioridazine—ADRA2A—endometrium—uterine cancer	0.000727	0.0152	CbGeAlD
Thioridazine—CYP2C19—vagina—uterine cancer	0.000726	0.0152	CbGeAlD
Thioridazine—Oedema—Dactinomycin—uterine cancer	0.000719	0.00377	CcSEcCtD
Thioridazine—HRH1—mammalian vulva—uterine cancer	0.000716	0.015	CbGeAlD
Thioridazine—Aplastic anaemia—Doxorubicin—uterine cancer	0.00071	0.00372	CcSEcCtD
Thioridazine—Thrombocytopenia—Dactinomycin—uterine cancer	0.000704	0.00369	CcSEcCtD
Thioridazine—ADRA2A—mammalian vulva—uterine cancer	0.000704	0.0147	CbGeAlD
Thioridazine—CYP2C8—female reproductive system—uterine cancer	0.0007	0.0146	CbGeAlD
Thioridazine—KCNH2—female gonad—uterine cancer	0.000696	0.0145	CbGeAlD
Thioridazine—Diarrhoea—Progesterone—uterine cancer	0.000696	0.00365	CcSEcCtD
Thioridazine—KCNH2—vagina—uterine cancer	0.000692	0.0145	CbGeAlD
Thioridazine—HTR2A—epithelium—uterine cancer	0.00069	0.0144	CbGeAlD
Thioridazine—Anorexia—Dactinomycin—uterine cancer	0.000685	0.00359	CcSEcCtD
Thioridazine—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.000679	0.00356	CcSEcCtD
Thioridazine—Photosensitivity—Epirubicin—uterine cancer	0.000676	0.00354	CcSEcCtD
Thioridazine—ADRA2A—uterus—uterine cancer	0.00067	0.014	CbGeAlD
Thioridazine—HTR2A—smooth muscle tissue—uterine cancer	0.000665	0.0139	CbGeAlD
Thioridazine—Vomiting—Progesterone—uterine cancer	0.000647	0.00339	CcSEcCtD
Thioridazine—Rash—Progesterone—uterine cancer	0.000642	0.00336	CcSEcCtD
Thioridazine—Dermatitis—Progesterone—uterine cancer	0.000641	0.00336	CcSEcCtD
Thioridazine—HTR2A—renal system—uterine cancer	0.00064	0.0134	CbGeAlD
Thioridazine—Headache—Progesterone—uterine cancer	0.000637	0.00334	CcSEcCtD
Thioridazine—CYP2C8—vagina—uterine cancer	0.000633	0.0132	CbGeAlD
Thioridazine—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.000631	0.00331	CcSEcCtD
Thioridazine—Dermatitis exfoliative—Epirubicin—uterine cancer	0.000629	0.0033	CcSEcCtD
Thioridazine—Photosensitivity—Doxorubicin—uterine cancer	0.000626	0.00328	CcSEcCtD
Thioridazine—Decreased appetite—Dactinomycin—uterine cancer	0.000625	0.00328	CcSEcCtD
Thioridazine—CYP2C9—female reproductive system—uterine cancer	0.000622	0.013	CbGeAlD
Thioridazine—HRH1—female reproductive system—uterine cancer	0.000613	0.0128	CbGeAlD
Thioridazine—Lethargy—Epirubicin—uterine cancer	0.000606	0.00317	CcSEcCtD
Thioridazine—Nausea—Progesterone—uterine cancer	0.000604	0.00317	CcSEcCtD
Thioridazine—ADRA2A—female reproductive system—uterine cancer	0.000603	0.0126	CbGeAlD
Thioridazine—Feeling abnormal—Dactinomycin—uterine cancer	0.000593	0.00311	CcSEcCtD
Thioridazine—CYP2E1—female reproductive system—uterine cancer	0.000589	0.0123	CbGeAlD
Thioridazine—Anaemia—Etoposide—uterine cancer	0.000589	0.00309	CcSEcCtD
Thioridazine—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.000586	0.00307	CcSEcCtD
Thioridazine—CYP2D6—renal system—uterine cancer	0.000583	0.0122	CbGeAlD
Thioridazine—Dermatitis exfoliative—Doxorubicin—uterine cancer	0.000582	0.00305	CcSEcCtD
Thioridazine—Rash—Medroxyprogesterone Acetate—uterine cancer	0.000581	0.00305	CcSEcCtD
Thioridazine—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.000581	0.00304	CcSEcCtD
Thioridazine—Headache—Medroxyprogesterone Acetate—uterine cancer	0.000578	0.00303	CcSEcCtD
Thioridazine—Leukopenia—Etoposide—uterine cancer	0.000571	0.00299	CcSEcCtD
Thioridazine—Body temperature increased—Dactinomycin—uterine cancer	0.000568	0.00298	CcSEcCtD
Thioridazine—Cardiac arrest—Epirubicin—uterine cancer	0.000564	0.00296	CcSEcCtD
Thioridazine—Lethargy—Doxorubicin—uterine cancer	0.00056	0.00294	CcSEcCtD
Thioridazine—HRH1—female gonad—uterine cancer	0.000558	0.0117	CbGeAlD
Thioridazine—HRH1—vagina—uterine cancer	0.000555	0.0116	CbGeAlD
Thioridazine—ADRA2A—female gonad—uterine cancer	0.000548	0.0115	CbGeAlD
Thioridazine—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000548	0.00287	CcSEcCtD
Thioridazine—ADRA2A—vagina—uterine cancer	0.000545	0.0114	CbGeAlD
Thioridazine—Hypersensitivity—Dactinomycin—uterine cancer	0.00053	0.00278	CcSEcCtD
Thioridazine—Confusional state—Etoposide—uterine cancer	0.000525	0.00275	CcSEcCtD
Thioridazine—Cardiac arrest—Doxorubicin—uterine cancer	0.000522	0.00274	CcSEcCtD
Thioridazine—Asthma—Epirubicin—uterine cancer	0.000513	0.00269	CcSEcCtD
Thioridazine—HTR2A—female reproductive system—uterine cancer	0.000512	0.0107	CbGeAlD
Thioridazine—Thrombocytopenia—Etoposide—uterine cancer	0.00051	0.00267	CcSEcCtD
Thioridazine—Tachycardia—Etoposide—uterine cancer	0.000508	0.00266	CcSEcCtD
Thioridazine—Eosinophilia—Epirubicin—uterine cancer	0.000508	0.00266	CcSEcCtD
Thioridazine—Hyperhidrosis—Etoposide—uterine cancer	0.000503	0.00264	CcSEcCtD
Thioridazine—Anorexia—Etoposide—uterine cancer	0.000496	0.0026	CcSEcCtD
Thioridazine—Diarrhoea—Dactinomycin—uterine cancer	0.000492	0.00258	CcSEcCtD
Thioridazine—Pancytopenia—Epirubicin—uterine cancer	0.000487	0.00255	CcSEcCtD
Thioridazine—Hypotension—Etoposide—uterine cancer	0.000486	0.00255	CcSEcCtD
Thioridazine—Asthma—Doxorubicin—uterine cancer	0.000475	0.00249	CcSEcCtD
Thioridazine—Eosinophilia—Doxorubicin—uterine cancer	0.00047	0.00246	CcSEcCtD
Thioridazine—Photosensitivity reaction—Epirubicin—uterine cancer	0.000468	0.00245	CcSEcCtD
Thioridazine—Weight increased—Epirubicin—uterine cancer	0.000467	0.00245	CcSEcCtD
Thioridazine—CYP2D6—female reproductive system—uterine cancer	0.000467	0.00975	CbGeAlD
Thioridazine—HTR2A—vagina—uterine cancer	0.000463	0.00968	CbGeAlD
Thioridazine—Somnolence—Etoposide—uterine cancer	0.000463	0.00243	CcSEcCtD
Thioridazine—Drowsiness—Epirubicin—uterine cancer	0.000457	0.0024	CcSEcCtD
Thioridazine—Vomiting—Dactinomycin—uterine cancer	0.000457	0.0024	CcSEcCtD
Thioridazine—Rash—Dactinomycin—uterine cancer	0.000453	0.00238	CcSEcCtD
Thioridazine—Decreased appetite—Etoposide—uterine cancer	0.000452	0.00237	CcSEcCtD
Thioridazine—Pancytopenia—Doxorubicin—uterine cancer	0.000451	0.00236	CcSEcCtD
Thioridazine—KCNH2—lymph node—uterine cancer	0.000448	0.00935	CbGeAlD
Thioridazine—Jaundice—Epirubicin—uterine cancer	0.000446	0.00234	CcSEcCtD
Thioridazine—Constipation—Etoposide—uterine cancer	0.000445	0.00233	CcSEcCtD
Thioridazine—Photosensitivity reaction—Doxorubicin—uterine cancer	0.000433	0.00227	CcSEcCtD
Thioridazine—Weight increased—Doxorubicin—uterine cancer	0.000432	0.00226	CcSEcCtD
Thioridazine—Feeling abnormal—Etoposide—uterine cancer	0.000429	0.00225	CcSEcCtD
Thioridazine—Nausea—Dactinomycin—uterine cancer	0.000427	0.00224	CcSEcCtD
Thioridazine—Agranulocytosis—Epirubicin—uterine cancer	0.000427	0.00224	CcSEcCtD
Thioridazine—CYP2D6—female gonad—uterine cancer	0.000425	0.00887	CbGeAlD
Thioridazine—Drowsiness—Doxorubicin—uterine cancer	0.000423	0.00222	CcSEcCtD
Thioridazine—Jaundice—Doxorubicin—uterine cancer	0.000413	0.00216	CcSEcCtD
Thioridazine—Body temperature increased—Etoposide—uterine cancer	0.000411	0.00216	CcSEcCtD
Thioridazine—Oedema peripheral—Epirubicin—uterine cancer	0.000405	0.00212	CcSEcCtD
Thioridazine—Agranulocytosis—Doxorubicin—uterine cancer	0.000395	0.00207	CcSEcCtD
Thioridazine—Hypersensitivity—Etoposide—uterine cancer	0.000383	0.00201	CcSEcCtD
Thioridazine—Oedema peripheral—Doxorubicin—uterine cancer	0.000374	0.00196	CcSEcCtD
Thioridazine—Arrhythmia—Epirubicin—uterine cancer	0.000367	0.00192	CcSEcCtD
Thioridazine—Mental disorder—Epirubicin—uterine cancer	0.00036	0.00189	CcSEcCtD
Thioridazine—HRH1—lymph node—uterine cancer	0.000359	0.00749	CbGeAlD
Thioridazine—Erythema—Epirubicin—uterine cancer	0.000357	0.00187	CcSEcCtD
Thioridazine—Diarrhoea—Etoposide—uterine cancer	0.000356	0.00187	CcSEcCtD
Thioridazine—ADRA2A—lymph node—uterine cancer	0.000352	0.00736	CbGeAlD
Thioridazine—Arrhythmia—Doxorubicin—uterine cancer	0.000339	0.00178	CcSEcCtD
Thioridazine—Vision blurred—Epirubicin—uterine cancer	0.000337	0.00177	CcSEcCtD
Thioridazine—Mental disorder—Doxorubicin—uterine cancer	0.000333	0.00174	CcSEcCtD
Thioridazine—Vomiting—Etoposide—uterine cancer	0.000331	0.00173	CcSEcCtD
Thioridazine—Erythema—Doxorubicin—uterine cancer	0.000331	0.00173	CcSEcCtD
Thioridazine—Anaemia—Epirubicin—uterine cancer	0.00033	0.00173	CcSEcCtD
Thioridazine—Agitation—Epirubicin—uterine cancer	0.000329	0.00172	CcSEcCtD
Thioridazine—Rash—Etoposide—uterine cancer	0.000328	0.00172	CcSEcCtD
Thioridazine—Dermatitis—Etoposide—uterine cancer	0.000328	0.00172	CcSEcCtD
Thioridazine—Headache—Etoposide—uterine cancer	0.000326	0.00171	CcSEcCtD
Thioridazine—Leukopenia—Epirubicin—uterine cancer	0.00032	0.00168	CcSEcCtD
Thioridazine—Vision blurred—Doxorubicin—uterine cancer	0.000312	0.00163	CcSEcCtD
Thioridazine—Nausea—Etoposide—uterine cancer	0.000309	0.00162	CcSEcCtD
Thioridazine—Anaemia—Doxorubicin—uterine cancer	0.000306	0.0016	CcSEcCtD
Thioridazine—Agitation—Doxorubicin—uterine cancer	0.000304	0.00159	CcSEcCtD
Thioridazine—Leukopenia—Doxorubicin—uterine cancer	0.000296	0.00155	CcSEcCtD
Thioridazine—Confusional state—Epirubicin—uterine cancer	0.000294	0.00154	CcSEcCtD
Thioridazine—Oedema—Epirubicin—uterine cancer	0.000292	0.00153	CcSEcCtD
Thioridazine—Thrombocytopenia—Epirubicin—uterine cancer	0.000286	0.0015	CcSEcCtD
Thioridazine—Tachycardia—Epirubicin—uterine cancer	0.000285	0.00149	CcSEcCtD
Thioridazine—Hyperhidrosis—Epirubicin—uterine cancer	0.000282	0.00148	CcSEcCtD
Thioridazine—Anorexia—Epirubicin—uterine cancer	0.000278	0.00146	CcSEcCtD
Thioridazine—Hypotension—Epirubicin—uterine cancer	0.000273	0.00143	CcSEcCtD
Thioridazine—Confusional state—Doxorubicin—uterine cancer	0.000272	0.00143	CcSEcCtD
Thioridazine—Oedema—Doxorubicin—uterine cancer	0.00027	0.00141	CcSEcCtD
Thioridazine—Thrombocytopenia—Doxorubicin—uterine cancer	0.000264	0.00139	CcSEcCtD
Thioridazine—Tachycardia—Doxorubicin—uterine cancer	0.000263	0.00138	CcSEcCtD
Thioridazine—Hyperhidrosis—Doxorubicin—uterine cancer	0.000261	0.00137	CcSEcCtD
Thioridazine—Somnolence—Epirubicin—uterine cancer	0.000259	0.00136	CcSEcCtD
Thioridazine—Anorexia—Doxorubicin—uterine cancer	0.000257	0.00135	CcSEcCtD
Thioridazine—Decreased appetite—Epirubicin—uterine cancer	0.000254	0.00133	CcSEcCtD
Thioridazine—Hypotension—Doxorubicin—uterine cancer	0.000252	0.00132	CcSEcCtD
Thioridazine—Constipation—Epirubicin—uterine cancer	0.000249	0.00131	CcSEcCtD
Thioridazine—Feeling abnormal—Epirubicin—uterine cancer	0.00024	0.00126	CcSEcCtD
Thioridazine—Somnolence—Doxorubicin—uterine cancer	0.00024	0.00126	CcSEcCtD
Thioridazine—Decreased appetite—Doxorubicin—uterine cancer	0.000235	0.00123	CcSEcCtD
Thioridazine—Constipation—Doxorubicin—uterine cancer	0.000231	0.00121	CcSEcCtD
Thioridazine—Body temperature increased—Epirubicin—uterine cancer	0.000231	0.00121	CcSEcCtD
Thioridazine—Feeling abnormal—Doxorubicin—uterine cancer	0.000222	0.00117	CcSEcCtD
Thioridazine—Hypersensitivity—Epirubicin—uterine cancer	0.000215	0.00113	CcSEcCtD
Thioridazine—Body temperature increased—Doxorubicin—uterine cancer	0.000213	0.00112	CcSEcCtD
Thioridazine—Diarrhoea—Epirubicin—uterine cancer	0.0002	0.00105	CcSEcCtD
Thioridazine—Hypersensitivity—Doxorubicin—uterine cancer	0.000199	0.00104	CcSEcCtD
Thioridazine—Vomiting—Epirubicin—uterine cancer	0.000186	0.000972	CcSEcCtD
Thioridazine—Diarrhoea—Doxorubicin—uterine cancer	0.000185	0.000968	CcSEcCtD
Thioridazine—Rash—Epirubicin—uterine cancer	0.000184	0.000964	CcSEcCtD
Thioridazine—Dermatitis—Epirubicin—uterine cancer	0.000184	0.000963	CcSEcCtD
Thioridazine—Headache—Epirubicin—uterine cancer	0.000183	0.000958	CcSEcCtD
Thioridazine—Nausea—Epirubicin—uterine cancer	0.000173	0.000908	CcSEcCtD
Thioridazine—Vomiting—Doxorubicin—uterine cancer	0.000172	0.0009	CcSEcCtD
Thioridazine—Rash—Doxorubicin—uterine cancer	0.00017	0.000892	CcSEcCtD
Thioridazine—Dermatitis—Doxorubicin—uterine cancer	0.00017	0.000891	CcSEcCtD
Thioridazine—Headache—Doxorubicin—uterine cancer	0.000169	0.000886	CcSEcCtD
Thioridazine—Nausea—Doxorubicin—uterine cancer	0.00016	0.00084	CcSEcCtD
Thioridazine—HTR1A—Signaling by GPCR—KRAS—uterine cancer	3.2e-06	0.000246	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—CXCL8—uterine cancer	3.18e-06	0.000244	CbGpPWpGaD
Thioridazine—HTR2C—Signaling by GPCR—KRAS—uterine cancer	3.18e-06	0.000244	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—EP300—uterine cancer	3.17e-06	0.000243	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—EP300—uterine cancer	3.17e-06	0.000243	CbGpPWpGaD
Thioridazine—DRD1—Signaling by GPCR—HRAS—uterine cancer	3.16e-06	0.000243	CbGpPWpGaD
Thioridazine—CHRM2—Signaling by GPCR—NRAS—uterine cancer	3.15e-06	0.000242	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling by GPCR—NRAS—uterine cancer	3.15e-06	0.000241	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—CDKN1B—uterine cancer	3.11e-06	0.000239	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—ESR1—uterine cancer	3.09e-06	0.000237	CbGpPWpGaD
Thioridazine—ADRA1B—GPCR downstream signaling—PIK3CA—uterine cancer	3.08e-06	0.000237	CbGpPWpGaD
Thioridazine—DRD1—GPCR downstream signaling—AKT1—uterine cancer	3.08e-06	0.000236	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—CYP19A1—uterine cancer	3.06e-06	0.000234	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—STK11—uterine cancer	3.06e-06	0.000234	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling by GPCR—KRAS—uterine cancer	3.05e-06	0.000234	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—CCL2—uterine cancer	3.04e-06	0.000233	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—VEGFA—uterine cancer	3e-06	0.000231	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—VEGFA—uterine cancer	3e-06	0.00023	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—CCL2—uterine cancer	2.99e-06	0.00023	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—CCL2—uterine cancer	2.99e-06	0.000229	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—NRAS—uterine cancer	2.97e-06	0.000228	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—NRAS—uterine cancer	2.96e-06	0.000227	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—MTHFR—uterine cancer	2.95e-06	0.000226	CbGpPWpGaD
Thioridazine—HTR1A—Signaling by GPCR—PIK3CA—uterine cancer	2.94e-06	0.000226	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—CTNNB1—uterine cancer	2.94e-06	0.000225	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—CCL2—uterine cancer	2.94e-06	0.000225	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—CCL2—uterine cancer	2.93e-06	0.000225	CbGpPWpGaD
Thioridazine—HTR2C—Signaling by GPCR—PIK3CA—uterine cancer	2.93e-06	0.000224	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling by GPCR—NRAS—uterine cancer	2.92e-06	0.000224	CbGpPWpGaD
Thioridazine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	2.91e-06	0.000223	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—ERBB2—uterine cancer	2.89e-06	0.000222	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—ERBB2—uterine cancer	2.87e-06	0.00022	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	2.87e-06	0.00022	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—PTEN—uterine cancer	2.86e-06	0.00022	CbGpPWpGaD
Thioridazine—DRD2—GPCR downstream signaling—PIK3CA—uterine cancer	2.84e-06	0.000218	CbGpPWpGaD
Thioridazine—DRD2—Signaling by GPCR—KRAS—uterine cancer	2.81e-06	0.000216	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling by GPCR—PIK3CA—uterine cancer	2.8e-06	0.000215	CbGpPWpGaD
Thioridazine—HTR2A—GPCR downstream signaling—PIK3CA—uterine cancer	2.8e-06	0.000215	CbGpPWpGaD
Thioridazine—DRD1—Signaling by GPCR—AKT1—uterine cancer	2.79e-06	0.000214	CbGpPWpGaD
Thioridazine—HRH1—GPCR downstream signaling—PIK3CA—uterine cancer	2.79e-06	0.000214	CbGpPWpGaD
Thioridazine—HTR2A—Signaling by GPCR—KRAS—uterine cancer	2.76e-06	0.000212	CbGpPWpGaD
Thioridazine—HRH1—Signaling by GPCR—KRAS—uterine cancer	2.76e-06	0.000212	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—ERBB2—uterine cancer	2.75e-06	0.000211	CbGpPWpGaD
Thioridazine—CHRM2—GPCR downstream signaling—PIK3CA—uterine cancer	2.75e-06	0.000211	CbGpPWpGaD
Thioridazine—ADRA1A—GPCR downstream signaling—PIK3CA—uterine cancer	2.74e-06	0.00021	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—CXCL8—uterine cancer	2.74e-06	0.00021	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—uterine cancer	2.74e-06	0.00021	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—EP300—uterine cancer	2.73e-06	0.00021	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—CXCL8—uterine cancer	2.72e-06	0.000209	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—CCL2—uterine cancer	2.72e-06	0.000209	CbGpPWpGaD
Thioridazine—HTR1A—Signaling by GPCR—HRAS—uterine cancer	2.72e-06	0.000209	CbGpPWpGaD
Thioridazine—CHRM2—Signaling by GPCR—KRAS—uterine cancer	2.71e-06	0.000208	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—MTHFR—uterine cancer	2.71e-06	0.000208	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling by GPCR—KRAS—uterine cancer	2.71e-06	0.000208	CbGpPWpGaD
Thioridazine—HTR2C—Signaling by GPCR—HRAS—uterine cancer	2.71e-06	0.000208	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—MTHFR—uterine cancer	2.69e-06	0.000206	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—CDKN1B—uterine cancer	2.67e-06	0.000205	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—CDKN1B—uterine cancer	2.66e-06	0.000204	CbGpPWpGaD
Thioridazine—HTR1A—GPCR downstream signaling—AKT1—uterine cancer	2.65e-06	0.000203	CbGpPWpGaD
Thioridazine—HTR2C—GPCR downstream signaling—AKT1—uterine cancer	2.63e-06	0.000202	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—CXCL8—uterine cancer	2.61e-06	0.0002	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	2.6e-06	0.000199	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling by GPCR—HRAS—uterine cancer	2.59e-06	0.000199	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—VEGFA—uterine cancer	2.59e-06	0.000198	CbGpPWpGaD
Thioridazine—DRD2—Signaling by GPCR—PIK3CA—uterine cancer	2.58e-06	0.000198	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—NRAS—uterine cancer	2.55e-06	0.000196	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—KRAS—uterine cancer	2.55e-06	0.000196	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—KRAS—uterine cancer	2.55e-06	0.000196	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—CDKN1B—uterine cancer	2.55e-06	0.000195	CbGpPWpGaD
Thioridazine—ADRA2A—GPCR downstream signaling—PIK3CA—uterine cancer	2.54e-06	0.000195	CbGpPWpGaD
Thioridazine—HTR2A—Signaling by GPCR—PIK3CA—uterine cancer	2.54e-06	0.000195	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—ERBB2—uterine cancer	2.54e-06	0.000195	CbGpPWpGaD
Thioridazine—HRH1—Signaling by GPCR—PIK3CA—uterine cancer	2.53e-06	0.000194	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—CTNNB1—uterine cancer	2.53e-06	0.000194	CbGpPWpGaD
Thioridazine—ADRA1B—GPCR downstream signaling—AKT1—uterine cancer	2.52e-06	0.000193	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling by GPCR—KRAS—uterine cancer	2.52e-06	0.000193	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—CTNNB1—uterine cancer	2.51e-06	0.000193	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—ERBB2—uterine cancer	2.49e-06	0.000191	CbGpPWpGaD
Thioridazine—CHRM2—Signaling by GPCR—PIK3CA—uterine cancer	2.49e-06	0.000191	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—ERBB2—uterine cancer	2.49e-06	0.000191	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling by GPCR—PIK3CA—uterine cancer	2.49e-06	0.000191	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—PTEN—uterine cancer	2.46e-06	0.000189	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—PTEN—uterine cancer	2.45e-06	0.000188	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—ERBB2—uterine cancer	2.45e-06	0.000188	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—ERBB2—uterine cancer	2.44e-06	0.000187	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—CTNNB1—uterine cancer	2.41e-06	0.000185	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—CXCL8—uterine cancer	2.4e-06	0.000184	CbGpPWpGaD
Thioridazine—HTR1A—Signaling by GPCR—AKT1—uterine cancer	2.4e-06	0.000184	CbGpPWpGaD
Thioridazine—HTR2C—Signaling by GPCR—AKT1—uterine cancer	2.39e-06	0.000183	CbGpPWpGaD
Thioridazine—DRD2—Signaling by GPCR—HRAS—uterine cancer	2.39e-06	0.000183	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	2.37e-06	0.000182	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—CXCL8—uterine cancer	2.37e-06	0.000181	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—CXCL8—uterine cancer	2.36e-06	0.000181	CbGpPWpGaD
Thioridazine—HTR2A—Signaling by GPCR—HRAS—uterine cancer	2.35e-06	0.00018	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—EP300—uterine cancer	2.35e-06	0.00018	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—CDKN1B—uterine cancer	2.35e-06	0.00018	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—PIK3CA—uterine cancer	2.35e-06	0.00018	CbGpPWpGaD
Thioridazine—HRH1—Signaling by GPCR—HRAS—uterine cancer	2.35e-06	0.00018	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—PTEN—uterine cancer	2.34e-06	0.00018	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—PIK3CA—uterine cancer	2.34e-06	0.00018	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—EP300—uterine cancer	2.34e-06	0.000179	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—CXCL8—uterine cancer	2.32e-06	0.000178	CbGpPWpGaD
Thioridazine—DRD2—GPCR downstream signaling—AKT1—uterine cancer	2.32e-06	0.000178	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—CXCL8—uterine cancer	2.32e-06	0.000178	CbGpPWpGaD
Thioridazine—ADRA2A—Metabolism—PTEN—uterine cancer	2.31e-06	0.000178	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling by GPCR—PIK3CA—uterine cancer	2.31e-06	0.000177	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—CDKN1B—uterine cancer	2.31e-06	0.000177	CbGpPWpGaD
Thioridazine—CHRM2—Signaling by GPCR—HRAS—uterine cancer	2.31e-06	0.000177	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—CDKN1B—uterine cancer	2.31e-06	0.000177	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling by GPCR—HRAS—uterine cancer	2.3e-06	0.000177	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—MTHFR—uterine cancer	2.3e-06	0.000176	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling by GPCR—AKT1—uterine cancer	2.29e-06	0.000176	CbGpPWpGaD
Thioridazine—HTR2A—GPCR downstream signaling—AKT1—uterine cancer	2.29e-06	0.000175	CbGpPWpGaD
Thioridazine—HRH1—GPCR downstream signaling—AKT1—uterine cancer	2.28e-06	0.000175	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—TP53—uterine cancer	2.27e-06	0.000174	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—ERBB2—uterine cancer	2.27e-06	0.000174	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—CDKN1B—uterine cancer	2.27e-06	0.000174	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—TP53—uterine cancer	2.27e-06	0.000174	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—CDKN1B—uterine cancer	2.26e-06	0.000174	CbGpPWpGaD
Thioridazine—CHRM2—GPCR downstream signaling—AKT1—uterine cancer	2.24e-06	0.000172	CbGpPWpGaD
Thioridazine—ADRA1A—GPCR downstream signaling—AKT1—uterine cancer	2.24e-06	0.000172	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—EP300—uterine cancer	2.24e-06	0.000172	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—VEGFA—uterine cancer	2.22e-06	0.000171	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—CTNNB1—uterine cancer	2.22e-06	0.00017	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—VEGFA—uterine cancer	2.21e-06	0.00017	CbGpPWpGaD
Thioridazine—ADRA2A—Metabolism—EP300—uterine cancer	2.21e-06	0.000169	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—KRAS—uterine cancer	2.2e-06	0.000169	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—NRAS—uterine cancer	2.2e-06	0.000169	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—NRAS—uterine cancer	2.19e-06	0.000168	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—CTNNB1—uterine cancer	2.18e-06	0.000167	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—CTNNB1—uterine cancer	2.18e-06	0.000167	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—HRAS—uterine cancer	2.17e-06	0.000167	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—HRAS—uterine cancer	2.17e-06	0.000166	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—PTEN—uterine cancer	2.16e-06	0.000166	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—CXCL8—uterine cancer	2.15e-06	0.000165	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—CTNNB1—uterine cancer	2.14e-06	0.000164	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling by GPCR—HRAS—uterine cancer	2.14e-06	0.000164	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—CTNNB1—uterine cancer	2.14e-06	0.000164	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—PTEN—uterine cancer	2.13e-06	0.000163	CbGpPWpGaD
Thioridazine—CYP2E1—Metabolism—PTEN—uterine cancer	2.13e-06	0.000163	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—PTEN—uterine cancer	2.12e-06	0.000163	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—VEGFA—uterine cancer	2.12e-06	0.000162	CbGpPWpGaD
Thioridazine—DRD2—Signaling by GPCR—AKT1—uterine cancer	2.11e-06	0.000162	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—CDKN1B—uterine cancer	2.1e-06	0.000161	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—NRAS—uterine cancer	2.09e-06	0.000161	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—PTEN—uterine cancer	2.09e-06	0.00016	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—PTEN—uterine cancer	2.08e-06	0.00016	CbGpPWpGaD
Thioridazine—ADRA2A—GPCR downstream signaling—AKT1—uterine cancer	2.08e-06	0.00016	CbGpPWpGaD
Thioridazine—HTR2A—Signaling by GPCR—AKT1—uterine cancer	2.08e-06	0.000159	CbGpPWpGaD
Thioridazine—HRH1—Signaling by GPCR—AKT1—uterine cancer	2.07e-06	0.000159	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—EP300—uterine cancer	2.06e-06	0.000158	CbGpPWpGaD
Thioridazine—CHRM2—Signaling by GPCR—AKT1—uterine cancer	2.04e-06	0.000156	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling by GPCR—AKT1—uterine cancer	2.03e-06	0.000156	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—EP300—uterine cancer	2.03e-06	0.000156	CbGpPWpGaD
Thioridazine—CYP2E1—Metabolism—EP300—uterine cancer	2.03e-06	0.000156	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—EP300—uterine cancer	2.02e-06	0.000155	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	2.02e-06	0.000155	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—PIK3CA—uterine cancer	2.02e-06	0.000155	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—EP300—uterine cancer	1.99e-06	0.000153	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—EP300—uterine cancer	1.99e-06	0.000152	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—CTNNB1—uterine cancer	1.99e-06	0.000152	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—TP53—uterine cancer	1.95e-06	0.00015	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—VEGFA—uterine cancer	1.95e-06	0.00015	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—PTEN—uterine cancer	1.94e-06	0.000148	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—NRAS—uterine cancer	1.93e-06	0.000148	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—VEGFA—uterine cancer	1.92e-06	0.000147	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—VEGFA—uterine cancer	1.92e-06	0.000147	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—AKT1—uterine cancer	1.92e-06	0.000147	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—AKT1—uterine cancer	1.91e-06	0.000147	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—NRAS—uterine cancer	1.9e-06	0.000146	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—NRAS—uterine cancer	1.89e-06	0.000145	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—KRAS—uterine cancer	1.89e-06	0.000145	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling by GPCR—AKT1—uterine cancer	1.89e-06	0.000145	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—VEGFA—uterine cancer	1.89e-06	0.000145	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—VEGFA—uterine cancer	1.88e-06	0.000144	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—KRAS—uterine cancer	1.88e-06	0.000144	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—HRAS—uterine cancer	1.87e-06	0.000143	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—NRAS—uterine cancer	1.86e-06	0.000143	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—NRAS—uterine cancer	1.86e-06	0.000143	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—EP300—uterine cancer	1.85e-06	0.000142	CbGpPWpGaD
Thioridazine—CYP2C8—Metabolism—PTEN—uterine cancer	1.84e-06	0.000141	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—KRAS—uterine cancer	1.8e-06	0.000138	CbGpPWpGaD
Thioridazine—CYP2C8—Metabolism—EP300—uterine cancer	1.75e-06	0.000134	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—VEGFA—uterine cancer	1.75e-06	0.000134	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—PIK3CA—uterine cancer	1.74e-06	0.000133	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—PIK3CA—uterine cancer	1.73e-06	0.000133	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—NRAS—uterine cancer	1.73e-06	0.000132	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—TP53—uterine cancer	1.68e-06	0.000129	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—TP53—uterine cancer	1.67e-06	0.000128	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—KRAS—uterine cancer	1.66e-06	0.000127	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—PIK3CA—uterine cancer	1.65e-06	0.000127	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—AKT1—uterine cancer	1.65e-06	0.000127	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—PTEN—uterine cancer	1.64e-06	0.000126	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—KRAS—uterine cancer	1.63e-06	0.000125	CbGpPWpGaD
Thioridazine—ADRA2A—Metabolism—PIK3CA—uterine cancer	1.63e-06	0.000125	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—KRAS—uterine cancer	1.63e-06	0.000125	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—HRAS—uterine cancer	1.61e-06	0.000123	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—KRAS—uterine cancer	1.6e-06	0.000123	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—TP53—uterine cancer	1.6e-06	0.000123	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—KRAS—uterine cancer	1.6e-06	0.000123	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—HRAS—uterine cancer	1.6e-06	0.000123	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—EP300—uterine cancer	1.56e-06	0.00012	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—HRAS—uterine cancer	1.53e-06	0.000117	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—PIK3CA—uterine cancer	1.53e-06	0.000117	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—PTEN—uterine cancer	1.51e-06	0.000116	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—PIK3CA—uterine cancer	1.5e-06	0.000115	CbGpPWpGaD
Thioridazine—CYP2E1—Metabolism—PIK3CA—uterine cancer	1.5e-06	0.000115	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—PIK3CA—uterine cancer	1.5e-06	0.000115	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—PTEN—uterine cancer	1.5e-06	0.000115	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—KRAS—uterine cancer	1.49e-06	0.000114	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—TP53—uterine cancer	1.48e-06	0.000113	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—PIK3CA—uterine cancer	1.47e-06	0.000113	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—PIK3CA—uterine cancer	1.47e-06	0.000113	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—TP53—uterine cancer	1.45e-06	0.000111	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—TP53—uterine cancer	1.45e-06	0.000111	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—EP300—uterine cancer	1.44e-06	0.00011	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—EP300—uterine cancer	1.43e-06	0.000109	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—TP53—uterine cancer	1.43e-06	0.000109	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—TP53—uterine cancer	1.42e-06	0.000109	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—AKT1—uterine cancer	1.42e-06	0.000109	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—AKT1—uterine cancer	1.41e-06	0.000108	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—HRAS—uterine cancer	1.41e-06	0.000108	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—HRAS—uterine cancer	1.39e-06	0.000107	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—HRAS—uterine cancer	1.39e-06	0.000106	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—PIK3CA—uterine cancer	1.37e-06	0.000105	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—HRAS—uterine cancer	1.36e-06	0.000105	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—HRAS—uterine cancer	1.36e-06	0.000104	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—AKT1—uterine cancer	1.35e-06	0.000104	CbGpPWpGaD
Thioridazine—ADRA2A—Metabolism—AKT1—uterine cancer	1.33e-06	0.000102	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—TP53—uterine cancer	1.32e-06	0.000101	CbGpPWpGaD
Thioridazine—CYP2C8—Metabolism—PIK3CA—uterine cancer	1.3e-06	9.94e-05	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—PTEN—uterine cancer	1.28e-06	9.8e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—HRAS—uterine cancer	1.26e-06	9.69e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—AKT1—uterine cancer	1.25e-06	9.56e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—AKT1—uterine cancer	1.23e-06	9.41e-05	CbGpPWpGaD
Thioridazine—CYP2E1—Metabolism—AKT1—uterine cancer	1.22e-06	9.4e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—AKT1—uterine cancer	1.22e-06	9.39e-05	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—EP300—uterine cancer	1.22e-06	9.35e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—AKT1—uterine cancer	1.2e-06	9.23e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—AKT1—uterine cancer	1.2e-06	9.21e-05	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—PIK3CA—uterine cancer	1.16e-06	8.87e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—AKT1—uterine cancer	1.12e-06	8.56e-05	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—PIK3CA—uterine cancer	1.06e-06	8.16e-05	CbGpPWpGaD
Thioridazine—CYP2C8—Metabolism—AKT1—uterine cancer	1.06e-06	8.12e-05	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—PIK3CA—uterine cancer	1.05e-06	8.09e-05	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—AKT1—uterine cancer	9.45e-07	7.25e-05	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—PIK3CA—uterine cancer	9.01e-07	6.92e-05	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—AKT1—uterine cancer	8.69e-07	6.67e-05	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—AKT1—uterine cancer	8.62e-07	6.61e-05	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—AKT1—uterine cancer	7.36e-07	5.65e-05	CbGpPWpGaD
